ADVERTISEMENT
LIVE DESK·Global markets desk·Last updated 14s ago
ADVERTISEMENT
Novara — A Smarter Way to Access Global Markets
Markets/EquitiesArticle

U.K. FTSE 100 hits record close as autos, pharma stocks lead gains

The blue-chip index rose 0.33% to a new all-time high, with Vistry Group and Melrose Industries among the top gainers. Gold futures edged higher while Brent crude fell over 3%.

PA
Priya Anand · Equities & Earnings Desk · 29 Aug 2026 · 23:50 · 1 min read
Share
U.K. FTSE 100 hits record close as autos, pharma stocks lead gains

U.K. equities advanced at Tuesday’s close, with the Investing.com United Kingdom 100 rising 0.33% to set a fresh record in London. Gains were broad-based but led by strength in the Automobiles & Parts, Household Goods & Home Construction and Pharmaceuticals & Biotech sectors.

Advancing issues outnumbered decliners by 1,024 to 666 on the London Stock Exchange, with 562 stocks unchanged. The index’s advance extended its rally into a new session, capping a day of steady buying interest.

Among individual movers, Vistry Group PLC led gains with a 16.31% surge to 312.40, while Melrose Industries PLC added 10.43% to finish at 510.20. AstraZeneca PLC rose 3.02% to 12,476.00. On the downside, Standard Chartered PLC fell 2.51% to 2,140.00, Diageo PLC declined 2.01% to 1,735.50 and WPP PLC shed 1.93% to 392.20.

Commodities showed mixed performance. December gold futures edged 0.07% higher to $4,700.99 per troy ounce, while October U.S. crude oil futures dropped 3.41% to $82.11 per barrel. The November Brent crude contract fell 3.48% to $87.39 per barrel.

Foreign exchange markets were little changed. The GBP/USD pair held steady at 1.36, while EUR/GBP was flat at 0.86. The U.S. Dollar Index futures fell 0.04% to 98.89.

This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
Share this story
PA
Written by
Priya Anand
Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

More from Priya Anand →
ADVERTISEMENT
ADVERTISEMENT